These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 32126455)

  • 1. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
    Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
    Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community-based study.
    Saini R; Rao R; Parmar A; Mishra AK; Ambekar A; Agrawal A; Dhingra N
    Drug Alcohol Rev; 2020 Jan; 39(1):93-97. PubMed ID: 31769134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.
    John WS; Wu LT
    Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
    Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
    Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases.
    Sugarman OK; Saloner B; Richards TM; Lasser EC; Heath T; Idries S; Weiner JP; Bandara S
    Drug Alcohol Depend; 2024 May; 258():111281. PubMed ID: 38599134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study.
    Raman SR; Ford CB; Hammill BG; Clark AG; Clifton DC; Jackson GL
    Addict Sci Clin Pract; 2023 Jul; 18(1):42. PubMed ID: 37434260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes.
    Samples H; Williams AR; Crystal S; Olfson M
    J Subst Abuse Treat; 2022 Aug; 139():108774. PubMed ID: 35337716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
    Bagley SM; Larochelle MR; Xuan Z; Wang N; Patel A; Bernson D; Silverstein M; Hadland SE; Land T; Samet JH; Walley AY
    Ann Emerg Med; 2020 Jan; 75(1):29-38. PubMed ID: 31591014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and county-level variation in outcomes following non-fatal opioid-involved overdose.
    Lowder EM; Amlung J; Ray BR
    J Epidemiol Community Health; 2020 Apr; 74(4):369-376. PubMed ID: 31919146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of treatment for opioid use disorder among birthing people.
    Kim K; Liu G; Dick AW; Choi SW; Agbese E; Corr TE; Hsuan C; Wright MS; Park S; Velott D; Leslie DL
    J Subst Use Addict Treat; 2024 Jun; 161():209289. PubMed ID: 38272119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries.
    Samples H; Nowels MA; Williams AR; Olfson M; Crystal S
    Am J Prev Med; 2023 Jul; 65(1):19-29. PubMed ID: 36906496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and protective factors for repeated overdose after opioid overdose survival.
    Suffoletto B; Zeigler A
    Drug Alcohol Depend; 2020 Apr; 209():107890. PubMed ID: 32058246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic.
    Tanz LJ; Jones CM; Davis NL; Compton WM; Baldwin GT; Han B; Volkow ND
    JAMA Netw Open; 2023 Jan; 6(1):e2251856. PubMed ID: 36662523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties.
    Cerdá M; Hamilton AD; Hyder A; Rutherford C; Bobashev G; Epstein JM; Hatna E; Krawczyk N; El-Bassel N; Feaster DJ; Keyes KM
    Epidemiology; 2024 May; 35(3):418-429. PubMed ID: 38372618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
    Kelty E; Hulse G
    Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Inequality in Receipt of Medications for Opioid Use Disorder.
    Barnett ML; Meara E; Lewinson T; Hardy B; Chyn D; Onsando M; Huskamp HA; Mehrotra A; Morden NE
    N Engl J Med; 2023 May; 388(19):1779-1789. PubMed ID: 37163624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.